Overexpression of SIRT1 is a poor prognostic factor for advanced colorectal cancer

Chinese Medical Journal

Volumn 127, Issue 11, 2014, Pages 2021-2024

  Jiang, Ke Wei ^a   Lyu, Liang ^a,b   Shen, Zhan Long ^a   Zhang, Ji Zhun ^a   Zhang, Hui ^a   Dong, Jian Qiang ^a   Yan, Yi Chao ^a   Liu, Fang Fang ^a   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Carcinogenesis; Colorectal cancer; Immunohistochemistry; Prognosis; Sirtuin 1 (SIRT1)

Indexed keywords

SIRTUIN 1; TUMOR MARKER;

ADULT; AGED; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SIRTUIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 84901660638     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20140044     Document Type: Article

References (21)

1. Guarente L, Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 2011; 364: 2235-2244.
2. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012; 13: 225-238.
3. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-392.
4. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PloS One 2008; 3: e1759.
5. Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Rad Biol Med 2012; 52: 2013-2037.
6. Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, et al. Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflam-mation in fibroblasts. PloS One 2011; 6: e27081.
7. Zhang Z, Lowry SF, Guarente L, Haimovich B. Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J Biol Chem 2010; 285: 41391-41401.
8. Ming M, Shea CR, Guo X, Li X, Soltani K, Han W, et al. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Nat Acad Sci U S A 2010; 107: 22623-22628.
9. Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 2009; 28: 445-460.
10. Chen HC, Jeng YM, Yuan RH, Hsu HC, Chen YL. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepato-cellular carcinoma and its expression predicts poor prognosis. Ann Sur Oncol 2012; 19: 2011-2019.
11. Sung JY, Kim R, Kim JE, Lee J. Balance between SIRT1 and DBC1 expression is lost in breast cancer. Cancer Sci 2010; 101: 1738-1744.
12. Feng AN, Zhang LH, Fan XS, Huang Q, Ye Q, Wu HY, et al. Expression of SIRT1 in gastric cardiac cancer and its clinico-pathologic signifcance. Int J Sur Pathol 2011; 19: 743-750.
13. Zhao G, Cui J, Zhang JG, Qin Q, Chen Q, Yin T, et al. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther 2011; 18: 920-928.
14. Stunkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M, et al. Function of the SIRT1 protein deacetylase in cancer. Biotechnol J 2007; 2: 1360-1368.
15. Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, et al. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 2009; 284: 18210-18217.
16. Jang SH, Min KW, Paik SS, Jang KS. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma. J Clin Pathol 2012; 65: 735-739.
17. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Ann Rev Pathol 2010; 5: 253-295.
18. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nu-cleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 2007; 282: 6823-6832.
19. Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller D V, et al. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci 2010; 6: 599-612.
20. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. Mir-200a regulates SIRT1 expression and epithelial to mesenchy-mal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 2011; 286: 25992-26002.
21. Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res 2005; 65: 10183-10187.